Global Health Limited — Updates, 14-11-2024: Press Release

Global Health Limited reported robust financial results for the quarter ending September 30, 2024. Total income reached ₹9,748 million, marking a 12.7% increase year-on-year and 10.4% sequential growth. EBITDA stood at ₹2,465 million, reflecting a 5.5% year-on-year rise and an impressive 18.4% increase from the previous quarter, with EBITDA margins at 25.3%. Profit after tax grew by 4.5% year-on-year to ₹1,308 million, with a margin of 13.4%.

In operational highlights, the company added 118 beds across its facilities and witnessed an increase in average occupied bed days by 9.1% y-o-y, resulting in a strong occupancy rate of 64.3%. There was also notable growth in both in-patient (8.8% y-o-y) and out-patient (6.6% y-o-y) counts, alongside a marginal increase in average revenue per occupied bed (ARPOB) by 1.9% to ₹62,140. The company also embarked on an agreement to operate a new 750-bed super-specialty hospital in Pitampura, further strengthening its strategic footprint in the region, indicating a positive outlook for growth moving forward.